Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v20-EN Version v9-FR
Language English French
Date Updated 2018-04-21 2018-03-15
Drug Identification Number 00382825 00382825
Brand name RIVOTRIL 0.5TAB RIVOTRIL 0.5TAB
Common or Proper name CLONAZEPAM CLONAZEPAM
Company Name HOFFMANN-LA ROCHE LIMITED HOFFMANN-LA ROCHE LIMITED
Ingredients CLONAZEPAM CLONAZEPAM
Strength(s) 0.5MG 0.5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size Bottles of 100 tablets Bottles of 100 tablets
ATC code N03AE N03AE
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2018-01-03 2018-01-03
Estimated end date 2018-05-11 2018-05-11
Actual end date 2018-04-20
Shortage status Resolved Actual shortage
Company comments Product has been released as of March 15th 2018 and is available for sale. Due to anticipated high demand driven by shortages with other manufacturers in the market, we anticipate another shortage to begin on March 29th 2018.
Health Canada comments